Ipamorelin 5mg – Research Peptide | Tides Lab

Ipamorelin is a synthetic pentapeptide classified as a selective growth hormone secretagogue studied in laboratory research contexts. It is structurally distinct from GHRH analogues and is commonly referenced in experimental models examining ghrelin receptor signalling pathways.

In research literature, ipamorelin is investigated for its interaction with the growth hormone secretagogue receptor (GHS-R1a), contributing to downstream endocrine signalling processes in controlled laboratory settings.

This 5mg lyophilised formulation is supplied at ≥99% purity and intended strictly for laboratory research purposes.

Key Features

• 5mg lyophilised Ipamorelin
• Selective growth hormone secretagogue
• Ghrelin receptor (GHS-R1a) analogue
• ≥99% purity
• Research use only
• Discreet Australian shipping

Mechanism Overview

Ipamorelin is studied for its selective interaction with the ghrelin receptor (GHS-R1a), differentiating it from broader-acting secretagogues. Research literature describes its role in influencing endocrine signalling pathways via receptor-mediated mechanisms.

Its receptor selectivity is one reason ipamorelin is frequently examined in comparative laboratory models alongside GHRH analogues such as CJC-1295.

Stability and Handling

Ipamorelin is supplied in lyophilised (freeze-dried) form to preserve stability during storage and transport. Standard laboratory handling considerations include:

• Refrigerated storage following reconstitution
• Protection from light exposure
• Avoiding repeated temperature fluctuations

Maintaining cold-chain integrity is particularly important in Australian shipping environments.

Research Use Only

Ipamorelin is supplied strictly for laboratory research and educational purposes. It is not approved for therapeutic use and is not intended for human consumption.